MEK5/ERK5/mef2: A novel signaling pathway affected by hepatitis C virus non-enveloped capsid-like particles

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 10, 2011, Pages 1854-1862

  Katsarou, Konstantina ^a   Tsitoura, Panagiota ^b   Georgopoulou, Urania ^a  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

^b INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

Author keywords

Cell signaling; ERK5; Hepatitis C virus; Mef2; Non enveloped capsid like particle (HCVne)

Indexed keywords

CLATHRIN; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE 5; MYOCYTE ENHANCER FACTOR 2; NONSTRUCTURAL PROTEIN 5A; VIRUS ENVELOPE PROTEIN;

ARTICLE; CONTROLLED STUDY; ENDOCYTOSIS; ENZYME ACTIVATION; GENE CONTROL; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; VIRUS CAPSID; VIRUS MORPHOLOGY; VIRUS PARTICLE;

ANIMALS; CAPSID PROTEINS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HEP G2 CELLS; HEPACIVIRUS; HUMANS; MADS DOMAIN PROTEINS; MAP KINASE KINASE 5; MITOGEN-ACTIVATED PROTEIN KINASE 7; MODELS, BIOLOGICAL; MYOGENIC REGULATORY FACTORS; SIGNAL TRANSDUCTION; SPODOPTERA; VIRAL CORE PROTEINS; VIRAL ENVELOPE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS; VIRION;

FLAVIVIRIDAE; HEPATITIS C VIRUS; MIRIDAE;

EID: 80051793256     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2011.06.015     Document Type: Article

References (66)

1. Dubuisson J. Hepatitis C virus proteins. World J. Gastroenterol. 2007, 13:2406-2415.
2. Dubuisson J., Helle F., Cocquerel L. Early steps of the hepatitis C virus life cycle. Cell. Microbiol. 2008, 10:821-827.
3. Moradpour D., Penin F., Rice C.M. Replication of hepatitis C virus. Nat. Rev. Microbiol. 2007, 5:453-463.
4. But D.Y., Lai C.L., Yuen M.F. Natural history of hepatitis-related hepatocellular carcinoma. World J. Gastroenterol. 2008, 14:1652-1656.
5. Tellinghuisen T.L., Evans M.J., von Hahn T., You S., Rice C.M. Studying hepatitis C virus: making the best of a bad virus. J. Virol. 2007, 81:8853-8867.
6. Andre P., Perlemuter G., Budkowska A., Brechot C., Lotteau V. Hepatitis C virus particles and lipoprotein metabolism. Semin. Liver Dis. 2005, 25:93-104.
7. Maillard P., Krawczynski K., Nitkiewicz J., Bronnert C., Sidorkiewicz M., Gounon P., Dubuisson J., Faure G., Crainic R., Budkowska A. Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients. J. Virol. 2001, 75:8240-8250.
8. Masalova O.V., Atanadze S.N., Samokhvalov E.I., Petrakova N.V., Kalinina T.I., Smirnov V.D., Khudyakov Y.E., Fields H.A., Kushch A.A. Detection of hepatitis C virus core protein circulating within different virus particle populations. J. Med. Virol. 1998, 55:1-6.
9. Katsarou K., Lavdas A.A., Tsitoura P., Serti E., Markoulatos P., Mavromara P., Georgopoulou U. Endocytosis of hepatitis C virus non-enveloped capsid-like particles induces MAPK-ERK1/2 signaling events. Cell. Mol. Life Sci. 2010, 67:2491-2506.
10. Katsarou K., Serti E., Tsitoura P., Lavdas A.A., Varaklioti A., Pickl-Herk A.M., Blaas D., Oz-Arslan D., Zhu R., Hinterdorfer P., Mavromara P., Georgopoulou U. Green fluorescent protein - tagged HCV non-enveloped capsid like particles: development of a new tool for tracking HCV core uptake. Biochimie 2009, 91:903-915.
11. Tsitoura P., Georgopoulou U., Petres S., Varaklioti A., Karafoulidou A., Vagena D., Politis C., Mavromara P. Evidence for cellular uptake of recombinant hepatitis C virus non-enveloped capsid-like particles. FEBS Lett. 2007, 581:4049-4057.
12. Wang X., Tournier C. Regulation of cellular functions by the ERK5 signalling pathway. Cell. Signal. 2006, 18:753-760.
13. Turjanski A.G., Vaque J.P., Gutkind J.S. MAP kinases and the control of nuclear events. Oncogene 2007, 26:3240-3253.
14. Mody N., Campbell D.G., Morrice N., Peggie M., Cohen P. An analysis of the phosphorylation and activation of extracellular-signal-regulated protein kinase 5 (ERK5) by mitogen-activated protein kinase kinase 5 (MKK5) in vitro. Biochem. J. 2003, 372:567-575.
15. English J.M., Pearson G., Hockenberry T., Shivakumar L., White M.A., Cobb M.H. Contribution of the ERK5/MEK5 pathway to Ras/Raf signaling and growth control. J. Biol. Chem. 1999, 274:31588-31592.
16. Sohn S.J., Sarvis B.K., Cado D., Winoto A. ERK5 MAPK regulates embryonic angiogenesis and acts as a hypoxia-sensitive repressor of vascular endothelial growth factor expression. J. Biol. Chem. 2002, 277:43344-43351.
17. Inchauspe G., Zebedee S., Lee D.H., Sugitani M., Nasoff M., Prince A.M. Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:10292-10296.
18. Georgopoulou U., Tsitoura P., Kalamvoki M., Mavromara P. The protein phosphatase 2A represents a novel cellular target for hepatitis C virus NS5A protein. Biochimie 2006, 88:651-662.
19. Boleti H., Smirlis D., Dalagiorgou G., Meurs E.F., Christoforidis S., Mavromara P. ER targeting and retention of the HCV NS4B protein relies on the concerted action of multiple structural features including its transmembrane domains. Mol. Membr. Biol. 2010, 27:50-74.
20. Lemercier C., Verdel A., Galloo B., Curtet S., Brocard M.P., Khochbin S. mHDA1/HDAC5 histone deacetylase interacts with and represses MEF2A transcriptional activity. J. Biol. Chem. 2000, 275:15594-15599.
21. Dinev D., Jordan B.W., Neufeld B., Lee J.D., Lindemann D., Rapp U.R., Ludwig S. Extracellular signal regulated kinase 5 (ERK5) is required for the differentiation of muscle cells. EMBO Rep. 2001, 2:829-834.
22. Mattera R., Bonifacino J.S. Ubiquitin binding and conjugation regulate the recruitment of Rabex-5 to early endosomes. EMBO J. 2008, 27:2484-2494.
23. Kalamvoki M., Mavromara P. Calcium-dependent calpain proteases are implicated in processing of the hepatitis C virus NS5A protein. J. Virol. 2004, 78:11865-11878.
24. Serti E., Doumba P.P., Thyphronitis G., Tsitoura P., Katsarou K., Foka P., Konstandoulakis M.M., Koskinas J., Mavromara P., Georgopoulou U. Modulation of IL-2 expression after uptake of hepatitis C virus non-enveloped capsid-like particles: the role of p38 kinase. Cell. Mol. Life Sci. 2011, 68:505-522.
25. Rovida E., Navari N., Caligiuri A., Dello Sbarba P., Marra F. ERK5 differentially regulates PDGF-induced proliferation and migration of hepatic stellate cells. J. Hepatol. 2008, 48:107-115.
26. Tsai W.L., Chung R.T. Viral hepatocarcinogenesis. Oncogene 2010, 29:2309-2324. E.
27. Burlone M.E., Budkowska A. Hepatitis C virus cell entry: role of lipoproteins and cellular receptors. J. Gen. Virol. 2009, 90:1055-1070.
28. Mody N., Leitch J., Armstrong C., Dixon J., Cohen P. Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway. FEBS Lett. 2001, 502:21-24.
29. Terasawa K., Okazaki K., Nishida E. Regulation of c-Fos and Fra-1 by the MEK5-ERK5 pathway. Genes Cells 2003, 8:263-273.
30. Ren X., Ma X., Li Y. All-trans retinoic acid regulates c-jun expression via ERK5 in cardiac myoblasts. J. Nutr. Biochem. 2007, 18:832-838.
31. Carvajal-Vergara X., Tabera S., Montero J.C., Esparis-Ogando A., Lopez-Perez R., Mateo G., Gutierrez N., Parmo-Cabanas M., Teixido J., San Miguel J.F., Pandiella A. Multifunctional role of Erk5 in multiple myeloma. Blood 2005, 105:4492-4499.
32. Cavanaugh J.E. Role of extracellular signal regulated kinase 5 in neuronal survival. Eur. J. Biochem. 2004, 271:2056-2059.
33. Kato Y., Kravchenko V.V., Tapping R.I., Han J., Ulevitch R.J., Lee J.D. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J. 1997, 16:7054-7066.
34. Marchetti A., Colletti M., Cozzolino A.M., Steindler C., Lunadei M., Mancone C., Tripodi M. ERK5/MAPK is activated by TGFbeta in hepatocytes and required for the GSK-3beta-mediated Snail protein stabilization. Cell. Signal. 2008, 20:2113-2118.
35. Buschbeck M., Ullrich A. The unique C-terminal tail of the mitogen-activated protein kinase ERK5 regulates its activation and nuclear shuttling. J. Biol. Chem. 2005, 280:2659-2667.
36. Yan C., Luo H., Lee J.D., Abe J., Berk B.C. Molecular cloning of mouse ERK5/BMK1 splice variants and characterization of ERK5 functional domains. J. Biol. Chem. 2001, 276:10870-10878.
37. Raviv Z., Kalie E., Seger R. MEK5 and ERK5 are localized in the nuclei of resting as well as stimulated cells, while MEKK2 translocates from the cytosol to the nucleus upon stimulation. J. Cell Sci. 2004, 117:1773-1784.
38. Gustin M.C., Albertyn J., Alexander M., Davenport K. MAP kinase pathways in the yeast Saccharomyces cerevisiae. Microbiol. Mol. Biol. Rev. 1998, 62:1264-1300.
39. Pearson G.W., Earnest S., Cobb M.H. Cyclic AMP selectively uncouples mitogen-activated protein kinase cascades from activating signals. Mol. Cell. Biol. 2006, 26:3039-3047.
40. Lee J.D., Ulevitch R.J., Han J. Primary structure of BMK1: a new mammalian map kinase. Biochem. Biophys. Res. Commun. 1995, 213:715-724.
41. Zhou G., Bao Z.Q., Dixon J.E. Components of a new human protein kinase signal transduction pathway. J. Biol. Chem. 1995, 270:12665-12669.
42. Dong F., Gutkind J.S., Larner A.C. Granulocyte colony-stimulating factor induces ERK5 activation, which is differentially regulated by protein-tyrosine kinases and protein kinase C. Regulation of cell proliferation and survival. J. Biol. Chem. 2001, 276:10811-10816.
43. Kato Y., Tapping R.I., Huang S., Watson M.H., Ulevitch R.J., Lee J.D. Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor. Nature 1998, 395:713-716.
44. Pearson G., English J.M., White M.A., Cobb M.H. ERK5 and ERK2 cooperate to regulate NF-kappaB and cell transformation. J. Biol. Chem. 2001, 276:7927-7931.
45. Esparis-Ogando A., Diaz-Rodriguez E., Montero J.C., Yuste L., Crespo P., Pandiella A. Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2. Mol. Cell. Biol. 2002, 22:270-285.
46. Erhardt A., Hassan M., Heintges T., Haussinger D. Hepatitis C virus core protein induces cell proliferation and activates ERK, JNK, and p38 MAP kinases together with the MAP kinase phosphatase MKP-1 in a HepG2 Tet-Off cell line. Virology 2002, 292:272-284.
47. Georgopoulou U., Caravokiri K., Mavromara P. Suppression of the ERK1/2 signaling pathway from HCV NS5A protein expressed by herpes simplex recombinant viruses. Arch. Virol. 2003, 148:237-251.
48. Mankouri J., Griffin S., Harris M. The hepatitis C virus non-structural protein NS5A alters the trafficking profile of the epidermal growth factor receptor. Traffic 2008, 9:1497-1509.
49. Panteva M., Korkaya H., Jameel S. Hepatitis viruses and the MAPK pathway: is this a survival strategy?. Virus Res. 2003, 92:131-140.
50. Chao T.H., Hayashi M., Tapping R.I., Kato Y., Lee J.D. MEKK3 directly regulates MEK5 activity as part of the big mitogen-activated protein kinase 1 (BMK1) signaling pathway. J. Biol. Chem. 1999, 274:36035-36038.
51. Hayashi M., Lee J.D., Kato Y., Kravchenko V.V., Tapping R.I., Han J., Ulevitch R.J., Lee J.D. Role of the BMK1/ERK5 signaling pathway: lessons from knockout mice. J. Mol. Med. 2004, 82:800-808. Epub 2004 Oct 2028.
52. Kamakura S., Moriguchi T., Nishida E. Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus. J. Biol. Chem. 1999, 274:26563-26571.
53. Bai X., Wu L., Liang T., Liu Z., Li J., Li D., Xie H., Yin S., Yu J., Lin Q., Zheng S. Overexpression of myocyte enhancer factor 2 and histone hyperacetylation in hepatocellular carcinoma. J. Cancer Res. Clin. Oncol. 2008, 134:83-91.
54. Black B.L., Olson E.N. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins. Annu. Rev. Cell Dev. Biol. 1998, 14:167-196.
55. Mao Z., Bonni A., Xia F., Nadal-Vicens M., Greenberg M.E. Neuronal activity-dependent cell survival mediated by transcription factor MEF2. Science 1999, 286:785-790.
56. Naya F.J., Olson E. MEF2: a transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation. Curr. Opin. Cell Biol. 1999, 11:683-688.
57. McKinsey T.A., Zhang C.L., Olson E.N. Control of muscle development by dueling HATs and HDACs. Curr. Opin. Genet. Dev. 2001, 11:497-504.
58. Han J., Jiang Y., Li Z., Kravchenko V.V., Ulevitch R.J. Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature 1997, 386:296-299.
59. Zhao M., New L., Kravchenko V.V., Kato Y., Gram H., di Padova F., Olson E.N., Ulevitch R.J., Han J. Regulation of the MEF2 family of transcription factors by p38. Mol. Cell. Biol. 1999, 19:21-30.
60. Battaglia S., Benzoubir N., Nobilet S., Charneau P., Samuel D., Zignego A.L., Atfi A., Brechot C., Bourgeade M.F. Liver cancer-derived hepatitis C virus core proteins shift TGF-beta responses from tumor suppression to epithelial-mesenchymal transition. PLoS One 2009, 4:e4355.
61. Zauli G., Davis B.R., Re M.C., Visani G., Furlini G., La Placa M. tat protein stimulates production of transforming growth factor-beta 1 by marrow macrophages: a potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppression. Blood 1992, 80:3036-3043.
62. Nishimoto N.E., S MAPK signalling: ERK5 versus ERK1/2. EMBO Rep. 2006, 7:782-786.
63. Y.S., Yao Z., Kalie E., Raviv Z., Seger R. Calcium regulation of EGF-induced ERK5 activation: role of Lad1-MEKK2 interaction. PLoS 2010, 5:e12627.
64. Abe J., Kusuhara M., Ulevitch R.J., Berk B.C., Lee J.D. Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase. J. Biol. Chem. 1996, 271:16586-16590.
65. Yan C., Takahashi M., Okuda M., Lee J.D., Berk B.C. Fluid shear stress stimulates big mitogen-activated protein kinase 1 (BMK1) activity in endothelial cells. Dependence on tyrosine kinases and intracellular calcium. J. Biol. Chem. 1999, 274:143-150.
66. Charmi S., Aguilo J.I., Garaude J., de Bettignies G., Jacquet C., Hipskind R.A., Singer D., Anel A., Villalba M. ERK5 knockdown generates mouse leukemia cells with low MHC classI levels that activate NK cells and block tumorigenesis. J. Immunol. 2009, 182:3398-3405.